Incannex welcomes world-leading psychedelics experts to advisory board

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Incannex Healthcare Ltd (ASX:IHL, NASDAQ: IXHL) director Peter Widdows tells Proactive the company has appointed three world-renowned psychedelic therapy and science experts to its Clarion Clinics Group Advisory Board. The Clarion Clinics Groups Pty Ltd is a collaborative venture between Incannex and three leading Australian psychedelics experts - Dr Paul Liknaitzky, Professor Suresh Sundram and Sean O’Carroll.

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744

Jonathan@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  256.52
-4.74 (-1.81%)
AAPL  315.20
+8.89 (2.90%)
AMD  521.54
+11.41 (2.24%)
BAC  52.48
+0.97 (1.88%)
GOOG  358.39
-14.19 (-3.81%)
META  597.63
-2.84 (-0.47%)
MSFT  441.31
-19.21 (-4.17%)
NVDA  222.82
-1.54 (-0.69%)
ORCL  244.58
-3.57 (-1.44%)
TSLA  423.74
+7.86 (1.89%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.